Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
M. Lebreton is a French medical device company specializing in the development and manufacturing of innovative tools for aesthetic medicine, primarily under the brand name SoftFil. The company is a global leader in the production of micro-cannulas used for the injection of dermal fillers, offering a range of specialized needles and injection systems designed to enhance precision and patient comfort. Their products, such as the SoftFil Precision and SoftFil Classic ranges, are engineered to reduce trauma, bruising, and downtime during cosmetic procedures. M. Lebreton also provides training and educational resources for healthcare professionals to optimize the use of their injection technologies. The company's commitment to research and development has established SoftFil as a benchmark for safety and quality in the non-surgical aesthetic industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on M. Lebreton.